Evidence map›Paper›PMID 36781034›Full record

ArticleMethods (San Diego, Calif.)2023

Site-specific labeling of SBDS to monitor interactions with the 60S ribosomal subunit.

Aparna Biswas, Yu-Fong Peng, Vikas Kaushik, Sofia Origanti

Open access · greenAbstract read
In one paragraph

Article in Methods (San Diego, Calif.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. RiboScreenBiomedicines · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Aparna BiswasDepartment of Biology, Saint Louis University, St. Louis, MO 63103, United States.
Yu-Fong PengDepartment of Biology, Saint Louis University, St. Louis, MO 63103, United States.
Vikas KaushikDepartment of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO 63104, United States.
Sofia OrigantiDepartment of Biology, Saint Louis University, St. Louis, MO 63103, United States. Electronic address: sofia.origanti@slu.edu.
Saint Louis University · USSaint Louis University · ES

Funding

Mechanism and Regulation of eIF6 in TranslationR01GM143179 · NIGMS · SAINT LOUIS UNIVERSITY · PI Sofia Origanti · 2022 to 2026
$1.8M
NIGMS NIH HHS R01 GM143179
6 · The paper itself

Abstract

The Shwachman-Diamond syndrome (SDS) is a rare inherited ribosomopathy that is predominantly caused by mutations in the Shwachman-Bodian-Diamond Syndrome gene (SBDS). SBDS is a ribosomal maturation factor that is essential for the release of eukaryotic translation initiation factor 6 (eIF6) from 60S ribosomal subunits during the late stages of 60S maturation. Release of eIF6 is critical to permit inter-subunit interactions between the 60S and 40S subunits and to form translationally competent 80S monosomes. SBDS has three key domains that are highly flexible and adopt varied conformations in solution. To better understand the domain dynamics of SBDS upon binding to 60S and to assess the effects of SDS-disease specific mutations, we aimed to site-specifically label individual domains of SBDS. Here we detail the generation of a fluorescently labeled SBDS to monitor the dynamics of select domains upon binding to 60S. We describe the incorporation of 4-azido-l-phenylalanine (4AZP), a noncanonical amino acid in human SBDS. Site-specific labeling of SBDS using fluorophore and assessment of 60S binding activity are also described. Such labeling approaches to capture the interactions of individual domains of SBDS with 60S are also applicable to study the dynamics of other multi-domain proteins that interact with the ribosomal subunits.

Indexed as

ProteinsRibosome Subunits, Large, EukaryoticHumansMutationRibosomesShwachman-Diamond SyndromeProteinsSBDS protein, human60SNoncanonical amino acid labelingSBDSShwachman-Diamond syndromeSite-specific labeling

Identifiers

PMID36781034
PMCPMC11827446
OpenAlexW4320033721

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.